Vancouver, BC Canada – August 2, 2016
Rostrum Medical Innovations Inc., a Canadian medical device developer announced that it has completed its ‘Series A’ offering being fully subscribed by YonghuaInvestment Management Co., Ltd. (“Yonghua Capital”) of Shanghai, PRC.
The company will use the funding to support and expand its clinical validation and to commence its commercialization program of the innovative respiratory monitoring system, the VQm®.
“Rostrum Medical continues to progress with its VQm® development, validation and commercialization program. The financial investment focus of the Yonghua Group compliments Rostrum’s streamlined approach to development and commercialization. We are excited to partner with such a dynamic and well managed international group as we continue our global mission to design and develop truly innovative and non-invasive solutions to patient care” says Awni Ayoubi, President & CEO of Rostrum Medical Innovations.
Linhua (Gary) Yang, Partner with Yonghua Investment Management is “very pleased to announce the deal with a Canadian company, marking a milestone in laying out Yonghua’s international strategy in Canada. Rostrum has a high-quality management and a robust R&D team, with the capacity to bring more innovations and care to global patients. Coupled with Yonghua’s financial support and specialized resources in medical industry in China, this will contribute to better development of both sides, facilitating investors’ belief in Yonghua’s value- investing philosophy.”
Rostrum Medical is poised to become a global medical device company, developing and refining new and useful links between medicines and biomedical engineering with innovative products that enhance patient care. Rostrum Medical is currently in strategic discussions with specialized distribution networks in Canada, Europe, Middle East and Asia.
About Rostrum Medical®
Rostrum Medical® is a privately held corporation, registered under the laws of Canada. Rostrum Medical® commenced its operation in January 2009, with a focus on providing medical practitioners with innovative and useful solutions to everyday challenges experienced in the healthcare industry. A team of leading clinicians, combined with engineering and business expertise, allows Rostrum Medical® to deliver leading edge solutions to problematic uncertainties in modern day practice.
About Yonghua Capital
Yonghua Capital is one of China’s most competitive private equity investors. As the primary investment vehicle of Yongjin Group, Yonghua Capital has rich experience in private equity investment and commits to become the most trustworthy financial service provider in the China capital market. So far Yonghua Capital has invested in over 100 outstanding companies, among which nearly 50 of which have been listed with stock exchanges.
A seasoned team of professional in industry research, finance, law and related regulatory policies, as well as the long-term cooperation with China’s well known underwriters, law firms, accounting firms and other intermediaries, Yonghua Capital has succeeded in finding the undervalued companies and obtaining returns from the capital market.
Press Contact Information:
Rostrum Medical Innovations Inc. .
Yonghua Investment Management Co., Ltd